In this chat, Jay Hancock will discuss how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Tune in to this Facebook Live as KHN senior correspondent Jay Hancock discusses these issues.